-Yuichi Ishikawa Researcher Activity Profile

Research Author Detailed Information 

Yuichi Ishikawa Publication Rate By Year

Yuichi Ishikawa has published 1 paper(s) in 2003, 20 paper(s) in 2007, 10 paper(s) in 2008, for a total of 31 research publications in total.

Yuichi Y Ishikawa Author Information

LAST NAME: ishikawa

FIRST NAME: yuichi

INITIALS: Y

AFFILIATION:

Papers

Yuichi Ishikawa's Publication Record

1. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Year Published: 2007
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. shinya.yamamoto@jfcr.or.jp
2. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Year Published: 2007
Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. s-kawakami@tmd.ac.jp
3. Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients. Year Published: 2007
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. s-kawakami@tmd.ac.jp
4. Obstinate cough as a sole presenting symptom of non-metastatic renal cell carcinoma. Year Published: 2007
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. yuhei.okubo@jfcr.or.jp
5. Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population. Year Published: 2007
Department of Geriatric Medicine, Kyoto University Graduate School of Medicine, Japan. harai@kuhp.kyoto-u.ac.jp
6. Solute-solvent interactions in imidazolium camphorsulfonate ionic liquids. Year Published: 2007
Department of Applied Chemistry, Faculty of Engineering, Oita University, Oita, 700 Dannoharu, Japan. ishichem@cc.oita-u.ac.jp.
7. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Year Published: 2007
Department of Urology, Graduate School, Tokyo Medical and Dental University Tokyo, Japan.
8. let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. Year Published: 2007
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.
9. Obstinate cough as a sole presenting symptom of non-metastatic renal cell carcinoma. Year Published: 2007
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. yuhei.okubo@jfcr.or.jp
10. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Year Published: 2007
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. shinya.yamamoto@jfcr.or.jp
11. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Year Published: 2007
Department of Urology, Graduate School, Tokyo Medical and Dental University Tokyo, Japan. noboru.uro@tmd.ac.jp
12. Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor. Year Published: 2007
Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, take_uro@ybb.ne.jp.
13. Solute-solvent interactions in imidazolium camphorsulfonate ionic liquids. Year Published: 2007
Department of Applied Chemistry, Faculty of Engineering, Oita University, Oita, 700 Dannoharu, Japan. ishichem@cc.oita-u.ac.jp
14. Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer. Year Published: 2007
Thoracic Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake 3-10-6, Koto-ku, Tokyo, 135-8550, Japan, mnishio@jfcr.or.jp.
15. let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. Year Published: 2007
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.
16. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. Year Published: 2008
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan.
17. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. Year Published: 2008
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan.
18. HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas. Year Published: 2007
Department of Pathology, The Cancer Institute, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
19. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. Year Published: 2008
Faculty of Health Sciences, Kobe University School of Medicine.
20. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. Year Published: 2008
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan.
21. Control of Cu(II) and Cu(III) states in N-confused porphyrin by protonation/deprotonation at the peripheral nitrogen. Year Published: 2003
Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.
22. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. Year Published: 2008
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan.
23. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. Year Published: 2008
Faculty of Health Sciences, Kobe University School of Medicine, Kobe, Japan. watanabe@kobe-u.ac.jp
24. Solute-solvent interactions in imidazolium camphorsulfonate ionic liquids. Year Published: 2007
Department of Applied Chemistry, Faculty of Engineering, Oita University, Oita, 700 Dannoharu, Japan. ishichem@cc.oita-u.ac.jp
25. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Year Published: 2007
Department of Urology, Graduate School, Tokyo Medical and Dental University Tokyo, Japan. noboru.uro@tmd.ac.jp
26. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Year Published: 2007
Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. s-kawakami@tmd.ac.jp
27. Etiologic value of p53 mutation spectra and differences with histology in lung cancers. Year Published: 2008
Laboratory of Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 1-1-2 Nakao, Asahi, Yokohama, Kanagawa 241-0815, Japan.
28. Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer. Year Published: 2007
Thoracic Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan.
29. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. Year Published: 2008
Faculty of Health Sciences, Kobe University School of Medicine, Kobe, Japan. watanabe@kobe-u.ac.jp
30. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Year Published: 2008
GeneCare Research Institute, TECOM 2nd Building, 19-2 Kajiwara, Kamakura, Kanagawa 247-0063, Japan.
31. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Year Published: 2008
GeneCare Research Institute, TECOM 2nd Building, 19-2 Kajiwara, Kamakura, Kanagawa 247-0063, Japan.